Mark W. Kroll, Director at HAEMONETICS CORP (HAE), sold 16,032 shares at $73.71 ($1.2M) on 2022-08-15, disclosed to the SEC on 2022-08-16.
Seasonal sale ($1.2M) by Director — this insider has traded HAE in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.71 | 8,016 | $591K | 50.0% |
| 2 | $73.71 | 8,016 | $591K | 50.0% |
| Total | $73.71 avg | 16,032 | $1.2M | 100% |
| Filing → |
| AXON | SELL | 2022-06-09 | $650K | — | Filing → |
| HAE | SELL | 2021-05-28 | $1.3M | — | Filing → |
| AXON | SELL | 2021-05-14 | $1.1M | — | Filing → |